Two steps forward, and one step back. This old saying aptly describes how I feel about my experience with Tremfya (guselkumab) after ten weeks. Overall I see progress. But during these seventy days I can point to a few setbacks. I see my dermatologist for the last time this week to discuss my situation and say goodbyes.
A little over a week ago I received the news that I would receive a somewhat new psoriasis medication, apremilast (Otezla), direct from the manufacturer. At first I felt a sense of relief that the battles with insurance over covering it came to an end. Then I faced the prospect of taking the medication. A feeling of dread overcame me.
Last week I finally conjured up the courage to call my insurance provider about the Otezla denial. Right away I knew why I procrastinated.